The study identified pivotal risk factors associated with LNM in CRC, including T stage, presence of vascular tumor thrombus, genetic markers (PMS2, MSH2, KRAS, BRAF), and neutrophil counts, while leukocytes displayed a protective effect. The gene discussed is PMS2; the disease is vascular neoplasm.